Following the European Parliament’s plenary vote on the sixth revision of the Carcinogens, Mutagens and Reprotoxic Substances Directive (CMRD 6) on 6 October, the European Federation of Nurses Associations (EFN), the European Federation of Public Service Unions… Read more
News
European Parliament Adopts Report on EU Health Workforce Crisis, Recognising Risks from Hazardous Medicinal Products
The European Parliament has adopted its own-initiative report “on an EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector” at plenary on 17 September 2026. The European… Read more
EBN Op-Ed on Occupational Exposure to Hazardous medicinal products (HMPs) Published in Social Europe
The European Biosafety Network is delighted to feature in Social Europe with an op-ed co-authored by Josh Cobb and Patrick Jahn, on the gap between EU law and ward-level practice in protecting nurses from hazardous medicinal products (HMPs). Read more
European guidance on hazardous medicinal products now available in 24 EU languages
The European Commission’s guidance on the safe management of hazardous medicinal products (HMPs) at work is now available in 24 EU languages. The guidance sets out practical measures to protect healthcare workers from occupational exposure to hazardous drugs,… Read more
Webinar: Formaldehyde Exposure in Healthcare – Risks, Regulation and Practical Solutions
We are delighted to share that our webinar examining the occupational risks of formaldehyde exposure in healthcare, hosted by the European Biosafety Network, had over 100 attendees across a range of professions. Attendees heard from Dr Acran Selman… Read more
EBN, EFN and EPSU publish a joint statement as CMRD 6 passes without Annex I inclusion, leaving healthcare professionals handling hazardous medicinal products unprotected
6 July 2026 Healthcare Professionals Handling Hazardous Medicinal Products Remain Unprotected as CMRD 6 Passes Without Annex I Inclusion Every day, nurses, pharmacists and many other healthcare professionals across Europe are exposed to hazardous chemotherapy drugs and… Read more
EBN Presents at BeSEDiM Webinar on Needle Safety
On 18 June 2026, Dr Philip Bickford Smith presented on behalf of the European Biosafety Network at An Evening with the Belgian Society of Emergency & Disaster Medicine (BeSEDiM): ‘Quality & Safety in EM: It’s Hot in… Read more
EBN, EFN and EPSU urge European Commission to support Annex I inclusion of hazardous medicinal products ahead of CMRD 6 trilogue
The European Biosafety Network, together with the European Federation of Nurses Associations (EFN), and the European Federation of Public Service Unions (EPSU), on behalf of the Stop Cancer At Work (SCAW) campaign has written jointly to the European Commission… Read more
EBN calls for dedicated EU action on hazardous medicinal products in EU4Health 2027
The European Biosafety Network has submitted a formal response to the European Commission’s targeted stakeholder consultation on the EU4Health work programme 2027, calling for the prevention of occupational exposure to hazardous medicinal products (HMPs) to be established as a… Read more
Webinar: Protecting Healthcare Workers from Formaldehyde Exposure: Risks, Regulation, and Solutions
Join us for a webinar on Thursday 2 July, 13:00 – 14:00 CET examining the occupational risks of formaldehyde exposure in healthcare and the practical steps organisations can take to protect their workforce. This webinar will… Read more
Study Finds Almost a Third of EU Healthcare Workers are Regularly Exposed to Cancer Risk Factors
A study conducted by the European Agency for Safety and Health at Work (EU-OSHA) shows that almost a third of EU healthcare and social workers are being regularly exposed to cancer-causing risks. The Workers’ Exposure Survey asked more… Read more
EBN Study Features in Leading Nursing Trade Publication
The European Biosafety Network is pleased to be featured in the Nursing Times and Labmate, which have covered our study on the occupational health risks of exposure to formalin and formaldehyde. Nursing Times article: https://www.nursingtimes.net/nurse-wellbeing/nurses-health-at-risk-from-toxic-levels-of-formaldehyde-13-05-2026/Labmate article:… Read more
Studie des EBN in „Bibliomed Pflege“ vorgestellt
Das European Biosafety Network freut sich über die Veröffentlichung in „Bibliomed Pflege“, in der unsere Studie zu den arbeitsmedizinischen Risiken einer Exposition gegenüber Formalin und Formaldehyd vorgestellt wurde. Den vollständigen Artikel finden Sie hier: https://www.bibliomed-pflege.de/news/formaldehyd-risiken-pflege-arbeitsschutz… Read more
Pressemitteilung: Formalin- und Formaldehyd-Exposition stellt erhebliche Risiken für die Gesundheit am Arbeitsplatz dar
Berlin, 12. Mai 2026: Tag für Tag sind Pflegekräfte und Laborpersonal in Krankenhäusern Formalin und Formaldehyd ausgesetzt – mit potenziell erheblichen gesundheitlichen Folgen, die von Asthma bis hin zu Krebs reichen können, und das trotz klarer regulatorischer Vorgaben zu… Read more
Press Release: Formalin and Formaldehyde Exposure Poses Significant Occupational Health Risks
London, 12 May 2026: Every day, nurses and laboratory staff across UK hospitals are exposed to Formalin and Formaldehyde with potentially significant harmful health effects ranging from asthma to cancer, despite clear regulatory guidelines on protection requirements from closed-system… Read more
EU Nurses Called to Help Build Evidence Base on Occupational Musculoskeletal Disorders
Musculoskeletal disorders (MSDs) remain one of the most significant occupational health challenges facing the nursing workforce in Europe, driven by the sustained physical demands of patient handling. Despite their prevalence, the European-level evidence base linking patient-handling practices… Read more
European Biosafety Network Publishes White Paper on Occupational Risks Posed by Formalin and Formaldehyde Exposure and Closed-System Solutions for Healthcare Workers
The European Biosafety Network (EBN) today publishes a new white paper examining the occupational risks posed by formalin and formaldehyde in healthcare settings across Europe and the United Kingdom, and the role of closed-system specimen containers in… Read more
Danish Cancer Cases Among University Doctors Prompt Calls for Formaldehyde Exposure Investigation
A cluster of cancer diagnoses among young medical workers at the University of Copenhagen has sparked calls for a formal investigation, after a new documentary from Danish broadcaster DR revealed that four student assistants who worked in the same… Read more
EBN study on healthcare worker exposure featured in German nursing media
New findings from a European Biosafety Network (EBN) study on occupational exposure to hazardous medicinal products have been featured in Bibliomed Pflege, one of Germany’s leading nursing publications: https://www.bibliomed-pflege.de/news/studie-zeigt-massive-luecken-beim-gefahrstoffschutz The article reports on a… Read more
National study reveals significant gap between safety regulations and actual practice in protecting oncology nurses in Germany
A landmark study reveals that three-quarters of nurses have experienced chemotherapy leaks, while training and workplace stress assessments remain only partially implemented. Berlin, Germany, 2nd March: Three-quarters of German nursing staff working in oncology are regularly exposed to chemotherapy drugs known as Hazardous Medicinal… Read more
New EBN with KOK Springer Pflege Publication Highlights Gaps in Protection for Oncology Nurses Handling HMPs
The European Biosafety Network (EBN) welcomes the publication of a new peer-reviewed article in Springer Pflege presenting the findings of a nationwide survey of more than 1,000 oncology nurses in Germany. The study provides one of the most comprehensive recent snapshots… Read more
EBN publishes article on occupational safety in oncology nursing in the Global Journal of Medical Therapeutics
The European Biosafety Network (EBN) has published an article in the Global Journal of Medical Therapeutics on “Occupational Safety in Oncology Nursing: Findings from a National Survey on the Handling of Cytotoxic Substances in Germany“. Oncology nurses… Read more
European Biosafety Network Publishes Whitepaper on Closed System Waste Disposal and Airtight Sealing of Hazardous Medicinal Products
The European Biosafety Network (EBN) today publishes a new white paper examining the critical role of closed-system disposal devices (CSDDs) and airtight sealing in protecting healthcare workers from exposure to Hazardous Medicinal Products (HMPs) during waste handling and disposal. Read more
EBN Addresses European Parliament on Healthcare Worker Protection from Hazardous Medicinal Products
On Wednesday 3 December, the European Biosafety Network (EBN) presented to the European Parliament’s Committee on Employment and Social Affairs (EMPL) on the implementation gap in protecting healthcare workers from hazardous medicinal products (HMPs). Josh Cobb, Secretary of… Read more
European Biosafety Network presents landmark research on oncology nurse safety in Germany at ESMO 2025
The European Biosafety Network (EBN) participated in the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, marking an important milestone in its ongoing work to improve the protection of healthcare workers from exposure to hazardous medicinal products… Read more
Joint Statement on the EMPL–SANT Own Initiative Report: Safe Staffing Levels and Protection from Hazardous Medicinal Products
The European Biosafety Network (EBN) and the European Federation of Nurses Associations (EFN) welcome the work of the European Parliament’s EMPL and SANT committees on the own initiative report “An EU health workforce crisis plan:… Read more
Joint Call for Action on Safe Staffing and Workforce Protection with CPME-EFN-PGEU
The European Biosafety Network (EBN) is proud to support this joint statement from the Standing Committee of European Doctors (CPME), the European Federation of Nurses Associations (EFN), and the Pharmaceutical Group of the European Union (PGEU)… Read more
Webinar: Ensuring Safety in the Handling of Cytotoxic Drugs
In May, the European Biosafety Network (EBN), in collaboration with the German Society for Oncological Nursing (KOK), hosted an informative and highly practical online webinar designed specifically for oncology nurses and healthcare professionals working with cytotoxic drugs. Read more
European Commission replies to question regarding adequacy of measures to protect staff handling hazardous medicinal products
On 28 May 2025, in collaboration with the European Biosafety Network, SANT Committee Group Coordinator Margarita de la Pisa Carrión MEP submitted a Written Question to the Commission. You can find the full text of the question here. Read more
EBN Urges EU Action on HMPs in Strasbourg Parliamentary Meetings
The European Biosafety Network (EBN) travelled to the European Parliament in Strasbourg on 7–8 July 2025 for a critical round of meetings with Members of the European Parliament (MEPs) to address the ongoing threat posed by hazardous medicinal products… Read more
EBN presents at OncoSafe Romania in Bucharest
On 22nd May 2025 the EBN presented at the OncoSafe Conference in Romanian Parliament, Bucharest. This was an educational conference dedicated to improving safety practices in the handling and administration of cytostatics, cytotoxics and other CMR hazardous substances collectively… Read more
The EBN, in partnership with the KOK, Launches Landmark Survey to Improve Safety for Oncology Nurses in Germany
2 April, 2025 Today, the EBN, in partnership with the Konferenz Onkologischer Kranken- und Kinderpflege (KOK), or German Oncology Nursing Association, has launched a landmark survey examining how German oncology nurses handle hazardous medicinal products (HMPs). The KOK… Read more
The European Biosafety Network presents at the Safer Cancer Care Conference, Brussels
On 7 March 2025, the European Biosafety Network (EBN) participated in the Safer Cancer Care Conference in Brussels, joining a distinguished panel of speakers, healthcare professionals, researchers, and policymakers. The event centred on a critical goal: raising awareness… Read more
The EU Commission publishes a European List of Hazardous Medicinal Products, Based on ETUI Research
Hazardous medicinal products (HMPs)—including many anti-cancer agents, antivirals, and immunosuppressants—are integral to treating serious diseases but can also pose risks to healthcare professionals. These drugs can cause cancer or reproductive disorders in exposed workers, underlining the urgent need for… Read more
BJN – Protecting workers from contamination and exposure to hazardous medicinal products and the potential health effects
Screenshot… Read more
EBN Secretary Ian Lindsley presents at ‘The Future of Automated Compounding’ in Łódź, Poland
The Future of Automated Compounding was held in the Puro Hotel, Łódź on 8-9 June 2024, attended by pharmacists from all over Poland. Ian Lindsley’s presentation focused on the EBN white paper on ‘Preventing contamination, exposure and health… Read more
Millions of healthcare workers get protection from new EU law today
From today’s date, millions of workers (mostly women) in Europe will be protected for the first time by EU and national law from the impact of regular exposure in the workplace to potentially life-threatening hazardous drugs – hazardous medicinal… Read more
Joint Summit: Preventing occupational exposure to Hazardous Medicinal Products (HMPs)
30th January 2024, 9.30am to 3pm, at Fórsa, Dublin A joint Summit on preventing occupational exposure to Hazardous Medicinal Products (HMPs) was held at Fórsa’s office in Dublin on 30th January 2024, hosted by Fórsa, the European Biosafety… Read more
EBN to host Joint Summit on Preventing occupational exposure to Hazardous Medicinal Products
On Tuesday 30 January, 10am-3pm, Fórsa and the European Biosafety Network (EBN), in association with the Hospital Pharmacists Association of Ireland and the National Association of Hospital Pharmacy Technicians, are hosting a one-day Joint Summit in Dublin. The summit… Read more
Further protection for workers and healthcare professionals approved by European Parliament today
The Stop Cancer at Work coalition welcomes the overwhelming vote today in the Employment Committee of the European Parliament for better protection for workers and healthcare professionals from potentially life-threatening hazardous medicinal products (HMPs). The campaign urges the European… Read more
EBN Secretary Ian Lindsley presents at Hazardous Drugs Conference in London
The Hazardous Drugs: Best Practice for Nurses and Healthcare Institutions was held at the Wellcome Collection, London on April 21st 2023, attended by Clinical Governance Directors, Cancer Services Directors, Lead Cancer Nurses, Pharmacists and healthcare policy makers from across… Read more
Survey: Preventing occupational exposure to Hazardous Medicinal Products (HMPs) in Ireland
New EU guidance on handling Hazardous Medicinal Products (HMPs) includes the following areas where there is a risk of occupational exposure: • Manufacturing • Reception and unpacking • Transport and storage • Preparation in pharmacies,… Read more
EBN Presentation: Is your pharmacy ready for EU legislation?
Ian Lindsley, Secretary of the European Biosafety Network, gave a presentation to the conference of the International Society of Oncology Pharmacy Practitioners, ISOPP 2023, in Seville on 3 March entitled ‘Is your pharmacy ready for EU legislation?’ He… Read more
Protecting health workers from hazardous products
IAN LINDSLEY, TONY MUSU and ADAM ROGALEWSKI 9th February 2023 There is more clarity about hazardous medicinal products but awareness still needs to be raised to protect workers. Health workers need protection at all stages of the… Read more
Prevention of occupational cancers in the health sector, EBN with ETUI unveil list of HMPs
Two and a half years ahead of the European Commission, the ETUI with the EBN has unveiled a list of 121 hazardous medicinal products (HMPs) commonly used in the healthcare sector that can cause cancer or reproductive disorders in professionals… Read more
ETUI Webinar: Cancer risks in healthcare workers
On 12 October, from 11-12h, CET, the ETUI is hosting a webinar on cancer risks in healthcare workers: identification of Hazardous Medicinal Products (HMPs). In the healthcare sector, 12.7 million workers across the EU are potentially exposed… Read more
ETUI Seminar on workers’ protection and chemicals
Ian Lindsley, Secretary of the EBN, attended the 18th Seminar on workers’ protection and chemicals in Zadar, Croatia from 28-29 June 2022. The seminar was organised by the European Trade Union Institute (ETUI) and is financially supported by the… Read more
Webinar on updating the ISO 23908 standard on safety mechanisms and the prevention of sharps injuries
22nd June 2022. Summary The webinar, chaired by Ian Lindsley, Secretary of the European Biosafety, was well-attended with over 50 attendees and strong engagement from participants. After welcoming attendees, Mr Lindsley talked through the agenda of the… Read more
Agenda for webinar on updating the ISO 23908 standard on safety mechanisms and the prevention of sharps injuries
On 22nd June 2022, the European Biosafety Network, in partnership with the Directorate-General for Health and Food Safety (DG SANTE) and the International Organisation for Standardisation (ISO), will host an online webinar on the prevention of sharps injuries and… Read more
Online workshops: Guidance document for the safe management of hazardous medicinal products at work
A consortium led by RPA is developing a Guidance document for the safe management of hazardous medicinal products at work (HMPs), under contract to the European Commission’s Directorate-General for Employment, Social Affairs and Inclusion (DG EMPL). The aim of the… Read more
Mental and Psychosocial Health in Healthcare; Preventing Medication Errors and Adverse Events and Disorders in Healthcare Workers
Aims and Objectives Improving the mental and psychosocial health and wellbeing of healthcare workers by understanding the causes and effects and preventing mental and psychosocial health disorders and adverse events , mainly medication errors; and by implementing traceability… Read more
Highlights of the outcome of CMD4 and the new provisions of the Carcinogens, Mutagens and Reprotoxins Directive
Inclusion of reprotoxic substances in the scope of the new Carcinogens, Mutagens and Reprotoxins Directive (CMRD). For 12 of these substances, a binding occupational maximum exposure level limit value will be introduced in Annex III of the Directive. Read more
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work
The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and hazardous medicinal products (HMPs) in the… Read more
Hazardous Drugs: Guide to Surface Monitoring
Nurses must have the greatest individual protection during the handling of hazardous drugs, guaranteeing at the same time adequate patient care, and must also be informed and trained on the risks associated with the activity they carry out,… Read more
ANSES report to the French government
The French health and safety agency ANSES has just published its report to the French government recommending the inclusion in French national legislation and the CMD of a list of cytostatic, or carcinogenic, drugs and agents (HMPs). … Read more
Stop Cancer at Work Campaign calls on European Commission to approve legislation
The Stop Cancer at Work (SCAW) Campaign calls on the European Commission to approve legislation now to protect workers and patients from getting cancer. The trilogue process with the European Council, Parliament and Commission under the Portuguese Presidency… Read more
EBN Webinar: Preventing sharps injuries, MDR and safety mechanism in medical devices
This morning the European Biosafety Network hosted a webinar on preventing sharps injuries, the MDR and safety mechanisms in medical devices. The webinar was attended by over 30 people with representation from healthcare employers, healthcare unions, expert medical professionals,… Read more
European healthcare workers suffered an increase of 276,000 sharps injuries due to COVID-19
New research published today from Ipsos MORI, on behalf of the European Biosafety Network, reveals that COVID-19 led to an increase of 276,000 (23%) in the number of sharps injuries to healthcare workers in Europe over the last year. Read more
Stop Cancer at Work Briefing Note on Inclusion of HMPs and Reprotoxins in the CMD
Every year more than 12.7 million healthcare workers in Europe are potentially exposed to carcinogenic, mutagenic and reprotoxic hazardous drugs (also known as hazardous medicinal products or HMPs). Studies show that hospital workers who handle cytotoxic (antineoplastic) drugs, used… Read more
EBN Webinar on Preventing Sharps Injuries, MDR and Safety Mechanism in Medical Devices
Agenda – EBN Webinar (Sharps, MDR and safety mechanism in medical devices) The European Biosafety Network is hosting a webinar on preventing sharps injuries, MDR and safety mechanism in medical devices. Read more
Critical Care Nurses in Poor Health More Likely to Make Medical Errors
The American Journal of Critical Care has this month published an article investigating the relationship between critical care nurses’ physical and mental health, their perception of workplace wellness support and self-reported medical errors. In a 2019 survey, 771… Read more
European Biosafety Network publishes new guidance to prevent sharps injuries
Healthcare workers and patients are being put at risk not only from COVID-19 but other deadly diseases as a result of an increase in sharps injuries entirely due to the pandemic. We must act now to stop this, not… Read more
European Parliament approves legislation to stop cancer at work
Stop Cancer at Work Campaign calls on European Commission and European Council to include hazardous drugs and reprotoxins in legislation now The European Parliament has confirmed the need for immediate legislative action – not just guidance – to… Read more
European Cancer Organisation publishes new ‘Working Against Cancer’ report
Today the European Cancer Organisation published a consensus paper conveying the critical challenges for the cancer workforce in the context of implementing Europe’s Beating Cancer Plan. The report, ‘Working Against Cancer: Giving Professionals the Right Tools for the… Read more
Stop Cancer at Work Campaign calls on European Commission to get on with including hazardous drugs in legislation now
Inclusion of hazardous drugs in EU legislation supported by the European Parliament, majority of Member States and consensus of stakeholders and responses to independent report published by the European Commission today The Stop Cancer at Work Campaign believes… Read more
European Parliament votes to stop cancer at work and include hazardous drugs and reprotoxins in the Carcinogens and Mutagens Directive (CMD)
Stop Cancer at Work Campaign calls on the European Commission to work with the Parliament and Council to legislate now to prevent workplace cancer The European Parliament voted today to support the Stop Cancer at Work campaign’s demands… Read more
Virtual Conference on Hospital Workers Wellbeing Matters
On 23rd February 2021, the International Society for Quality in Healthcare (ISQa) and the International Hospital Federation (IHF) held a virtual conference on hospital workers wellbeing matters. The event provided ISQa’s and IHF’s members and the wider community a global… Read more
The Spanish Society of Hospital Pharmacists release guidance on the monitoring of hazardous drugs
Spanish pharmacists draw up a consensus document to govern monitoring of hazardous drugs in hospital pharmacies Ten recommendations include aspects related to the drugs to be monitored; the areas to be monitored; when samples should be taken; risk… Read more
European Parliament Employment Committee Exchange of Views on CMD4 – 23 Feb 2021
Protection of workers from exposure to carcinogens or mutagens at work – CMD4 Speakers from the Stop Cancer at Work campaign and other experts gave presentations to the Employment and Social Affairs Committee of the European Parliament alongside… Read more
As part of World Patient Safety Day, the WHO produce a new charter: ‘Healthcare worker safety: a priority for patient safety’
As part of World Patient Safety Day in September 2020, the World Health Organisation presented a new Charter: ‘healthcare worker safety: a priority for patient safety’. The Charter is dedicated to the millions of health workers fighting COVID-19… Read more
Medication Errors: The Second Victim
“All medication errors are potentially avoidable. They can thus be greatly reduced or even prevented by improving the systems and practices of medication, including ordering, prescription, preparation, dispensing, administration and monitoring.” World Health Organization (WHO) 2017. (1) The Problem … Read more
Press statement for launch of Stop Cancer at Work Campaign
Today a broad coalition of professional organisations, trades unions and patient groups are launching the Stop Cancer at Work Campaign to ensure that the current fourth revision of the Carcinogens and Mutagens Directive (CMD) includes… Read more
HOSPEEM-EPSU position on the European Commission study supporting the assessment of different options concerning the protection of workers from exposure to hazardous medicinal products
Source: HOSPEEM. Brussels, 24/09/2020 Every year more than 12.7 million healthcare workers in Europe, including 7.3 million nurses, are potentially exposed to carcinogenic, mutagenic and reprotoxic hazardous drugs. Studies show that hospital workers who handle cytotoxic… Read more
Position Statement on Rapid Antigen Point of Care Tests for COVID and Influenza
A number of new diagnostic tests for SARS CoV2 are being and will be launched in the coming weeks with rapid point of care antigen tests being the most important technological innovation. Some months ago, the US Federal Drug… Read more
COVID and Influenza Preparedness in Europe
The COVID-19 pandemic and its repercussions will continue for some time and is likely to continue to place an ongoing burden on already stretched healthcare workers and patients in Europe, which will be exacerbated if it coincides with the… Read more
COVID-19 Vaccination Programme
COVID-19 vaccination is the most important global healthcare initiative at the moment and by the end of 2020/beginning of 2021, it is expected that pharmaceutical companies will start to deliver the first vaccines in Europe but probably not enough… Read more
EBN feedback to Europe’s Beating Cancer Plan
Preventing exposure to carcinogenic hazardous drugs Europe’s Beating Cancer Plan for Europe has to consider the potential benefits for workers, the healthcare system, patients and their families, by what has already identified as a preventive instrument in the roadmap,… Read more
Summary of European Biosafety Network Lisbon Summit
On 5 December 2019 the European Biosafety Network hosted a Summit at Infarmed in Lisbon to explore the issue of preventing the exposure of healthcare workers to hazardous drugs. Luca Scarpiello of EPSU said there is a… Read more
Summary of European Biosafety Network Rome Summit
On 29 October 2019 the European Biosafety Network held a Summit at the Italian Ministry of Health in Rome to discuss the exposure of healthcare workers to hazardous drugs. The Summit was split into three sessions including… Read more
Castilla-La Mancha hazardous drugs exposure prevention guidelines published by EBN
Guidelines published in August 2018 by the Health Service of Castilla-La Mancha (SESCAM) have been translated and published in English by the EBN. The guidelines cover all aspects of the dangers of exposure to hazardous drugs, along with prevention measures… Read more
EBN observatory on current biosafety practice in European Oncology reveals shortfalls in hospital safety standards across the EU
Click here to download report: Observatory on current biosafety practice in European Oncology More information on the observatory, including the data and conclusions by country, can be found here A report commissioned… Read more
EBN holds roundtable in the European Parliament on the prevention of exposure to hazardous drugs
The roundtable attracted more than 40 attendees from across the EU On Thursday 7th March, the European Biosafety Network (EBN) organised a roundtable of more than 40 participants in the European Parliament on the prevention of exposure to hazardous… Read more
